124 related articles for article (PubMed ID: 1851407)
1. [The efficacy and side effects of chemotherapy for primary lung cancer with cisplatin and etoposide].
Tsutsumi T; Kawakami A; Ozawa Y; Kawaguchi H; Fujii H; Sawano T; Asamoto H
Gan To Kagaku Ryoho; 1991 May; 18(6):1003-6. PubMed ID: 1851407
[TBL] [Abstract][Full Text] [Related]
2. [Adriamycin, cisplatin and etoposide combination chemotherapy in non-small cell lung cancer].
Yamaji Y; Fujita J; Kamei M; Futami H; Hashimoto Y; Bungo M; Nakamura H; Hata Y; Shiotani T; Irino S
Gan To Kagaku Ryoho; 1991 Apr; 18(4):601-6. PubMed ID: 1849390
[TBL] [Abstract][Full Text] [Related]
3. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
4. [A comparative randomized phase II study of CDDP, CDDP-carboquone (CQ) and CDDP-etoposide as second-line chemotherapy in small cell lung cancer (SCLC)].
Kobayashi K; Hino M; Kurane S; Yano T; Niitani H; Yamano Y; Hasegawa K; Tuboi E
Gan To Kagaku Ryoho; 1989 Feb; 16(2):207-12. PubMed ID: 2537605
[TBL] [Abstract][Full Text] [Related]
5. Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer.
Chewaskulyong B; Thongprasert S
J Med Assoc Thai; 1998 Jan; 81(1):37-41. PubMed ID: 9470320
[TBL] [Abstract][Full Text] [Related]
6. [Phase II study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancer].
Sugita T; Matsunaga K; Kobayashi H; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N; Matsumoto H; Okazaki M; Katagami N
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2479-83. PubMed ID: 7944494
[TBL] [Abstract][Full Text] [Related]
7. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
Irino S; Fujita J; Yamaji Y; Futami H; Hashimoto Y; Bungo M; Iuchi Y; Kamei M; Nakamura H; Hata Y
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin.
Dhingra HM; Valdivieso M; Booser DJ; Umsawasdi T; Carr DT; Chiuten DF; Murphy WK; Issell BF; Spitzer G; Farha P
Cancer Treat Rep; 1984 Apr; 68(4):671-3. PubMed ID: 6538811
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
Miller AA; Rosner GL; Ratain MJ; Hollis DR; Green MR; Schilsky RL
Clin Cancer Res; 1997 May; 3(5):719-25. PubMed ID: 9815741
[TBL] [Abstract][Full Text] [Related]
10. [Etoposide and cisplatin combination chemotherapy in a patient with small cell lung carcinoma under artificial hemodialysis].
Ono S; Miyazaki T; Nishikawa K; Watanabe K; Hisanaga S
Gan To Kagaku Ryoho; 1992 Jan; 19(1):115-8. PubMed ID: 1309629
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
12. [CDDP-containing combination chemotherapy for advanced lung cancer].
Asamoto H; Hisa T; Sawano T; Sakai K; Kitamura S; Matsushita N; Kokura M; Satake H; Kawakami I
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2544-9. PubMed ID: 6210053
[TBL] [Abstract][Full Text] [Related]
13. [A phase II study of NK171 (etoposide)].
Kimura K; Niitani H
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P
Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
[TBL] [Abstract][Full Text] [Related]
15. [A phase II study of oral VP-16 in primary lung cancer].
Matsui Y; Ohshima S; Kado M; Nakayama M; Shimokata K; Sakai S; Ito F; Chikata E; Hara K; Kanda T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
[TBL] [Abstract][Full Text] [Related]
16. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Unsal M; Erturk D
Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
[TBL] [Abstract][Full Text] [Related]
18. [Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin].
Takahashi T; Mori K; Suga Y; Tominaga K
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1873-5. PubMed ID: 8397491
[No Abstract] [Full Text] [Related]
19. [Acute myocardial infarction induced by lung cancer chemotherapy with cisplatin and etoposide].
Tsutsumi T; Ozawa Y; Kawakami A; Fujii H; Asamoto H
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):413-7. PubMed ID: 2155588
[TBL] [Abstract][Full Text] [Related]
20. Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
Ardizzoni A; Fusco V; Gulisano M; Pronzato P; Baracco F; Capaccio A; Pastorino G; Nosenzo M; Felletti R; Fabiano F
Cancer Treat Rep; 1987 Dec; 71(12):1311-2. PubMed ID: 2825994
[No Abstract] [Full Text] [Related]
[Next] [New Search]
